1. United States
2. Pa.
3. Letter

The Trump administration's indefinite suspension on research grant reviews, travel, and trainings at the National Institutes of Health (NIH) is deeply concerning. This unprecedented freeze will have devastating consequences for the scientific community, particularly early-career researchers whose careers and livelihoods depend on timely grant funding decisions. Additionally, the removal of diversity-related content and initiatives from the NIH website signals a concerning shift away from efforts to address structural racism and promote equity in biomedical research. The NIH plays a vital role in funding groundbreaking biomedical research that drives scientific progress and improves public health outcomes. Disrupting the agency's normal operations jeopardizes its ability to fulfill this critical mission. A protracted pause will force researchers to seek employment elsewhere, lead to missed milestones that impede career advancement, and ultimately impede scientific discovery. Lifting this freeze as soon as possible is imperative to safeguarding the NIH's essential functions and the broader biomedical research enterprise in the United States. The administration must act swiftly to restore normal operations at the agency and reaffirm its commitment to promoting diversity, equity, and inclusion in science. The potential impacts of this suspension are far too severe to allow it to persist.